2017 proposed revisions to the McDonald diagnostic criteria for multiple sclerosis
ECTRIMS Online Library. Cohen J. 10/26/17; 202448; 93
Jeffrey Cohen
Jeffrey Cohen
Contributions
Abstract

Abstract: 93

Type: Oral

Diagnostic criteria for multiple sclerosis have undergone successive revision and refinement. All of the versions of diagnostic criteria represent a compromise between sensitivity, to facilitate making the diagnosis efficiently and now that treatment options exist to allow appropriate early institution of disease therapy, and specificity, to lessen the risk of misdiagnosis. The International Panel on Diagnosis of MS met in Philadelphia in November 2016 and Berlin in May 2017 under the auspices of the International Advisory Committee on Clinical Trials in MS with the support of the US National MS Society and ECTRIMS. The Panel consensus workshop assessed the performance of the current 2010 McDonald Criteria to address these competing goals and review new data that have accumulated since the last Panel meeting that led to the 2010 Criteria. This presentation will summarize those discussions and the resultant proposed revisions to the McDonald Criteria.
Disclosure: Dr. Cohen received personal compensation for consulting for Adamas and Celgene, and as a Co-Editor of Multiple Sclerosis Journal - Experimental, Translational and Clinical.

Abstract: 93

Type: Oral

Diagnostic criteria for multiple sclerosis have undergone successive revision and refinement. All of the versions of diagnostic criteria represent a compromise between sensitivity, to facilitate making the diagnosis efficiently and now that treatment options exist to allow appropriate early institution of disease therapy, and specificity, to lessen the risk of misdiagnosis. The International Panel on Diagnosis of MS met in Philadelphia in November 2016 and Berlin in May 2017 under the auspices of the International Advisory Committee on Clinical Trials in MS with the support of the US National MS Society and ECTRIMS. The Panel consensus workshop assessed the performance of the current 2010 McDonald Criteria to address these competing goals and review new data that have accumulated since the last Panel meeting that led to the 2010 Criteria. This presentation will summarize those discussions and the resultant proposed revisions to the McDonald Criteria.
Disclosure: Dr. Cohen received personal compensation for consulting for Adamas and Celgene, and as a Co-Editor of Multiple Sclerosis Journal - Experimental, Translational and Clinical.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies